SCHEMBL13660722

SCHEMBL13660722

COC(=O)CCc1cccc(NC(=O)C(c2ccc(CN3N=C(c4ccccc4)CCC3=O)cc2)C(C)C(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.43
PDE4B Q07343 3/20 0.42
PDE3A Q14432 2/20 0.42
PDE4A P27815 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
PDE3B Q13370 1/20 0.42
PGR P06401 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
THRB P10828 2/20 0.39
TP53 P04637 5/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 2/20 0.38
PDE5A O76074 1/20 0.37
ALDH1A1 P00352 1/20 0.37
PTPN1 P18031 1/20 0.37
PARP1 P09874 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7606114 0.92 SMN1; SMN2 (0.44) SMN1; SMN2PDE4BPDE3APDE4APDE4C
SCHEMBL1178300 0.87 PTPN1 (0.36) PTPN1PARP1
SCHEMBL13660729 0.87 PGR (0.43) SMN1; SMN2PDE4BPDE3APDE4APDE4C
SCHEMBL7605856 0.85 SMN1; SMN2 (0.44) SMN1; SMN2PDE4BPDE3APDE4APDE4C
SCHEMBL13660725 0.83 SMN1; SMN2 (0.41) SMN1; SMN2PDE4BPDE3APDE4APDE4C
SCHEMBL7605706 0.83 PARP1 (0.48) SMN1; SMN2PDE4BPDE3APDE4APDE4C
SCHEMBL12872074 0.82 PTGES (0.43) SMN1; SMN2PDE4BPDE3APDE4APDE4C
SCHEMBL1178693 0.81 MAOB (0.33) PARP1
SCHEMBL1081126 0.81 PTGES (0.40) PARP1
SCHEMBL7602037 0.79 PTGES (0.47) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009127338-A1 OXO-HETEROCYCLIC SUBSTITUTED CARBOXYLIC ACID DERIVATES AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-10-22 WO disclosed